111 related articles for article (PubMed ID: 37972446)
1. Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer.
Luo YC; Lv YL; He RX; Shi XX; Jiang T
Biochem Biophys Res Commun; 2023 Dec; 689():149217. PubMed ID: 37972446
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Petraki C; Youssef YM; Dubinski W; Lichner Z; Scorilas A; Pasic MD; Komborozos V; Khalil B; Streutker C; Diamandis EP; Yousef GM
Tumour Biol; 2012 Aug; 33(4):1209-14. PubMed ID: 22437349
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis and clinical evaluation of kallikrein-related peptidase 10 (KLK10) in colorectal cancer.
Talieri M; Alexopoulou DK; Scorilas A; Kypraios D; Arnogiannaki N; Devetzi M; Patsavela M; Xynopoulos D
Tumour Biol; 2011 Aug; 32(4):737-44. PubMed ID: 21487810
[TBL] [Abstract][Full Text] [Related]
6. KLK10 promotes the progression of KRAS mutant colorectal cancer via PAR1-PDK1-AKT signaling pathway.
Wu K; Wu B; Yan K; Ding Q; Miao Z
Cell Biol Int; 2024 Apr; 48(4):440-449. PubMed ID: 38115179
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
Wei H; Dong C; Shen Z
Neoplasma; 2020 Jul; 67(4):889-897. PubMed ID: 32386481
[TBL] [Abstract][Full Text] [Related]
8. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
9. MiR-194-3p modulates the progression of colorectal cancer by targeting KLK10.
Liu T; Fang Y
Histol Histopathol; 2022 Mar; 37(3):301-309. PubMed ID: 34935123
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB
Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372
[TBL] [Abstract][Full Text] [Related]
11. MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10.
Xu LJ; Duan Y; Wang P; Yin HQ
Biochem Biophys Res Commun; 2018 Sep; 503(2):556-563. PubMed ID: 29807015
[TBL] [Abstract][Full Text] [Related]
12. Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity in vitro.
Li L; Xu N; Fan N; Meng Q; Luo W; Lv L; Ma W; Liu X; Liu L; Xu F; Wang H; Mao W; Li Y
Oncol Rep; 2015 Nov; 34(5):2325-32. PubMed ID: 26479703
[TBL] [Abstract][Full Text] [Related]
13. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer.
Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA
Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672
[TBL] [Abstract][Full Text] [Related]
14. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
White NM; Chow TF; Mejia-Guerrero S; Diamandis M; Rofael Y; Faragalla H; Mankaruous M; Gabril M; Girgis A; Yousef GM
Br J Cancer; 2010 Apr; 102(8):1244-53. PubMed ID: 20354523
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
[TBL] [Abstract][Full Text] [Related]
16. Frequent transcriptional inactivation of Kallikrein 10 gene by CpG island hypermethylation in non-small cell lung cancer.
Zhang Y; Song H; Miao Y; Wang R; Chen L
Cancer Sci; 2010 Apr; 101(4):934-40. PubMed ID: 20180809
[TBL] [Abstract][Full Text] [Related]
17. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
Luo LY; Grass L; Diamandis EP
Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187
[TBL] [Abstract][Full Text] [Related]
18. [Enhancement of kallikrein-related peptidase 10 expression attenuates proliferation and invasiveness of human tongue cancer cells in vitro].
Zheng H; Zhang W; Wang X; Zhao G
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1796-9. PubMed ID: 23268413
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
20. Kallikrein 10 (KLK10) methylation as a novel prognostic biomarker in early breast cancer.
Kioulafa M; Kaklamanis L; Stathopoulos E; Mavroudis D; Georgoulias V; Lianidou ES
Ann Oncol; 2009 Jun; 20(6):1020-5. PubMed ID: 19150938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
